Endo International Ordinary Shares reported $5.65M in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
Amarin AMRN:US USD -3883000 60.92M
Coherus Biosciences CHRS:US USD -58870000 27.78M
Eli Lilly And LLY:US USD 2.04B 38.3M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Hikma Pharmaceutical HIK:LN USD 269M 18M
Horizon Pharma HZNP:US USD 340.7M 25.6M
JAZZ PHA JAZZ:US USD -46767000 464.14M
Merk MRK:US USD 4.89B 560M
Novartis NOVN:VX USD 3.86B 195M
Pacira Pharmaceuticals PCRX:US USD 46.48M 4.25M
Patterson Companies PDCO:US USD 78.68M 835K
Perrigo Ordinary Shares PRGO:US USD 112.7M 16M
Pfizer PFE:US USD 7.38B 3.3B
Revance Therapeutics RVNC:US USD -145952000 61.96M
Supernus Pharmaceuticals SUPN:US USD 35.14M 35.58M
Takeda 4502:JP JPY 107.15B 42.6B
Teva Pharmaceutical TEVA:IT USD -1100000000 1.87B
Xeris Pharmaceuticals Inc XERS:US USD -13268000 8.9M
Zoetis ZTS:US USD 679M 35M